Search Results - "Bergseth, Grethe"
-
1
An international serum standard for application in assays to detect human complement activation products
Published in Molecular immunology (15-12-2013)“…The importance of the complement system in clinical medicine has become evident during the last decades and complement therapeutics has now reached the clinic…”
Get full text
Journal Article -
2
Human genetic deficiencies reveal the roles of complement in the inflammatory network: Lessons from nature
Published in Proceedings of the National Academy of Sciences - PNAS (15-09-2009)“…Complement component C5 is crucial for experimental animal inflammatory tissue damage; however, its involvement in human inflammation is incompletely…”
Get full text
Journal Article -
3
NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies
Published in mAbs (01-01-2020)“…The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are eculizumab…”
Get full text
Journal Article -
4
Artificial Surface-Induced Inflammation Relies on Complement Factor 5: Proof From a Deficient Person
Published in The Annals of thoracic surgery (01-02-2011)“…Background Exposing blood to artificial surfaces results in an inflammatory response, including complement activation and cytokine release. The aim of this…”
Get full text
Journal Article -
5
Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
Published in Case reports in nephrology (2018)“…We report a pediatric patient with atypical hemolytic uremic syndrome due to a C3 gain-of-function mutation diagnosed in infancy. She was treated from the…”
Get full text
Journal Article -
6
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report
Published in Medicine (Baltimore) (01-03-2017)“…Antiphospholipid syndrome (APS) in pregnancy may trigger the life-threatening catastrophic antiphospholipid syndrome (CAPS). Complement activation is…”
Get full text
Journal Article -
7
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome
Published in Medicine (Baltimore) (01-03-2017)“…Rationale:Antiphospholipid syndrome (APS) in pregnancy may trigger the lifethreatening catastrophic antiphospholipid syndrome (CAPS). Complement activation is…”
Get full text
Journal Article -
8
Platelet compatibility of an artificial surface modified with functionally active heparin
Published in Thrombosis and haemostasis (01-09-1999)“…Platelet compatibility after coating an artificial material with functionally active heparin was investigated. Blood was circulated in uncoated or heparin…”
Get more information
Journal Article -
9
A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity
Published in The Journal of immunology (1950) (15-09-2021)“…Thrombin activation of C5 connects thrombosis to inflammation. Complement research in whole blood ex vivo necessitates anticoagulation, which potentially…”
Get full text
Journal Article -
10
Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
Published in Immunobiology (1979) (01-04-2015)“…Abstract Eculizumab is a humanized IgG2/4 chimeric anti-complement C5 antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) or…”
Get full text
Journal Article -
11
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Published in Rheumatology (Oxford, England) (01-07-2016)“…Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment…”
Get full text
Journal Article -
12
NHDL, a recombinant V L /V H hybrid antibody control for IgG2/4 antibodies
Published in mAbs (01-01-2020)“…The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are eculizumab…”
Get full text
Journal Article -
13
Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome
Published in Clinical immunology (Orlando, Fla.) (01-10-2015)“…Abstract Complement C5 inhibitor eculizumab treatment in atypical hemolytic uremic syndrome is effective, but associated with high costs. Complement inhibition…”
Get full text
Journal Article -
14
Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses
Published in Molecular immunology (01-09-2017)“…•Antibodies to neoepitopes are crucial tools for detection of complement activation.•Changes of complement proteins without activation can expose…”
Get full text
Journal Article -
15
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
Published in Blood (01-09-2002)“…Complement plays an essential role in inflammation and tissue damage. However, it is largely unknown to what extent the system acts as a primary inducer of…”
Get full text
Journal Article -
16
A novel human whole blood model preventing fibrin formation reveals that thrombin does not cleave plasma C5 under physiological conditions
Published in Molecular immunology (01-10-2018)Get full text
Journal Article -
17
Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo
Published in Blood (09-07-2015)Get full text
Journal Article -
18
-
19
Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) – an ex vivo study with blood from a C5‐deficient individual
Published in APMIS : acta pathologica, microbiologica et immunologica Scandinavica (01-04-2018)“…The aim of the study was to investigate the role of complement factor 5 (C5) in reactions elicited by plasma separation using blood from a C5‐deficient (C5D)…”
Get full text
Journal Article -
20
Neoepitope based assays to detect C5a – Pitfalls and interpretations
Published in Molecular immunology (01-09-2017)Get full text
Journal Article